BDTX CIK: 1701541

Black Diamond Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−127
FY22:
−92.8
FY23:
−86.5
FY24:
−78.8
FY25:
12.5
(positive)
Change from FY21 to FY24
millions USD
FY21:
−127
FY22:
−94.6
FY23:
−86.0
FY24:
−78.4
FY25:
–
(positive)
Change from FY21 to FY24
millions USD
FY21:
−126
FY22:
−91.2
FY23:
−82.4
FY24:
−69.7
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−126
FY22:
−91.2
FY23:
−82.4
FY24:
−69.7
FY25:
22.4

All amounts in millions USD Data sources:SEC EDGARTwelve Data